Drugs Made In America Acquisition DMAAR SEC Filings

NASDAQ DMAAR
$0.13 +0.01 (+8.33%)
At close: Sep 17, 2026 · 4:00 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Drugs Made In America Acquisition Corp. (DMAAR) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index